DocDollars

Bausch & Lomb Americas Inc.

NJ · United States · Reporting entity ID 100001116887

Total reported 2019–2025
$65.9M
#137 of 2,960 reporting companies — 0.1% of all reported industry payments
$48.5M in general payments across 289,010 records, plus $17.3M in research funding across 1,031 records.

How it breaks down

General payments $48,548,031
Research funding $17,331,168

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Bausch & Lomb Americas Inc. reported $65.9M to US doctors and teaching hospitals from 2019 to 2025, ranking #137 of 2,960 reporting companies. 26% of that was research funding and 74% general payments such as consulting, speaking, food and travel. 289,010 general payment records and 1,031 research records were filed.

Common questions about Bausch & Lomb Americas Inc.

How much has Bausch & Lomb Americas Inc. paid US doctors?

Bausch & Lomb Americas Inc. reported $65,879,198 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $48,548,031 in general payments, $17,331,168 in research funding.

How does Bausch & Lomb Americas Inc. rank among drug and device companies?

It ranks #137 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Bausch & Lomb Americas Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.